Clinician Denial of Patient Requests Impacts Satisfaction

Share this content:
Clinician Denial of Patient Requests Impacts Satisfaction
Clinician Denial of Patient Requests Impacts Satisfaction

TUESDAY, Nov. 28, 2017 (HealthDay News) -- Clinician denial of some types of tests requested by patients is associated with worse patient satisfaction with the clinician, according to a study published online Nov. 27 in JAMA Internal Medicine.

Anthony Jerant, M.D., from the University of California Davis School of Medicine in Sacramento, and colleagues conducted a cross-sectional study involving 1,319 outpatient visits to family physicians by 1,141 adults. Patient satisfaction with the visit physician was measured using six Consumer Assessment of Healthcare Providers and Systems Clinician and Group Adult Visit survey items. The items were averaged to form the satisfaction score. The adjusted mean differences in patient satisfaction percentile were examined in association with denial versus fulfillment of each of seven requests (referral, pain medication, antibiotics, other new medication, laboratory tests, radiology test, or other test).

The researchers found that 68.0 percent of the 1,319 visits included at least one request, and 85.2 percent were fulfilled. Worse satisfaction was seen in association with clinician denials of requests for referral, pain medication, other new medication, and laboratory tests, compared with fulfillment of the respective request type (adjusted mean percentile differences, −19.75, −10.72, −20.36, and −9.19, respectively).

"In an era of patient satisfaction-driven compensation, the findings suggest the need to train clinicians to deal effectively with requests, potentially enhancing patient and clinician experiences," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab + Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »